我国新增医疗服务价格项目管理现状与对策研究  

Status quo and countermeasures of the new medical service price items management in China

作　　者：林燕羡 刘宝[1] Lin Yanxian;Liu Bao(School of Public Health,Fudan University,Key Lab of Health Technology Assessment,National Health Commission,Shanghai 200032,China)

机构地区：[1]复旦大学公共卫生学院国家卫生健康委员会卫生技术评估重点实验室,上海200032

出　　处：《中华医院管理杂志》2021年第11期878-882,共5页Chinese Journal of Hospital Administration

基　　金：国家自然科学基金(72074050)。

摘　　要：新增医疗服务价格项目(以下简称新增项目)管理是深化医疗服务价格改革的重要组成部分。笔者梳理了我国新增项目管理政策发展历程及各省份管理现状, 发现我国新增项目管理中存在新增项目内涵界定不清晰、与《全国医疗服务价格项目规范》的衔接未理顺、审批流程不完善、定价基础薄弱以及转归制度待加强等问题, 建议尽快出台并贯彻执行统一的全国医疗服务价格项目规范和新增项目管理的指导意见, 推进新增项目管理与医疗服务价格动态调整机制的衔接, 加强新增项目管理的制度建设。New medical service price items(hereinafter referred to as the new item)management is key to deepening medical service price reform.Based on the review of the policy development of the new item management and status quo of provincial-level practices,the authors sorted out the problems in the new item management as follows.Namely the new item connotation was not clearly defined,linkage with the national specifications for medical service price items was not yet well defined,the approval process was imperfect,the pricing fundamentals were weak,and the maturity term system was to be strengthened.According to such analyses,the authors proposed countermeasure recommendations for optimizing the new item management:to introduce and implement unified national specifications for medical service price item and the new item guidance as quickly as possible,to promote the linkage between the new item management and the dynamic adjustment mechanism of medical service prices,and to strengthen institutional construction of the new item management.

关 键 词：医疗服务价格 新增医疗服务价格项目 卫生政策 管理现状 

分 类 号：R197.1[医药卫生—卫生事业管理]